↓ Skip to main content

Carbamazepine for schizophrenia.

Overview of attention for article published in Cochrane database of systematic reviews, May 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
18 tweeters

Readers on

mendeley
71 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Carbamazepine for schizophrenia.
Published in
Cochrane database of systematic reviews, May 2014
DOI 10.1002/14651858.cd001258.pub3
Pubmed ID
Authors

Leucht S, Helfer B, Dold M, Kissling W, McGrath J

Abstract

Many people with schizophrenia do not achieve a satisfactory treatment response with just antipsychotic drug treatment and various adjunct medications are used to promote additional response. The antiepileptic carbamazepine is one such drug.

Twitter Demographics

The data shown below were collected from the profiles of 18 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 1%
Spain 1 1%
South Africa 1 1%
Denmark 1 1%
Unknown 67 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 18%
Researcher 12 17%
Student > Bachelor 10 14%
Student > Ph. D. Student 9 13%
Other 6 8%
Other 21 30%
Readers by discipline Count As %
Medicine and Dentistry 43 61%
Psychology 14 20%
Agricultural and Biological Sciences 4 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Social Sciences 3 4%
Other 4 6%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2016.
All research outputs
#894,032
of 8,345,240 outputs
Outputs from Cochrane database of systematic reviews
#3,249
of 8,584 outputs
Outputs of similar age
#21,999
of 179,924 outputs
Outputs of similar age from Cochrane database of systematic reviews
#88
of 200 outputs
Altmetric has tracked 8,345,240 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,584 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.4. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,924 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 200 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.